Article Text

PDF
Risperidone effectively increases rates of symptomatic remission of acute mania in people with bipolar disorder

Statistics from Altmetric.com


 
 Q Does risperidone increase symptomatic remission of acute mania in people with bipolar disorder?

METHODS

Embedded ImageDesign:

Randomised controlled trial.

Embedded ImageAllocation:

Unclear.

Embedded ImageBlinding:

Double blind.

Embedded ImageFollow up period:

Three weeks.

Embedded ImageSetting:

Eight hospitals, India. Recruitment: March 2001 to December 2001.

Embedded ImagePatients:

291 people (aged 18–65 years) with bipolar I disorder (manic or mixed) (DSM-IV; Young Mania Rating Scale (YMRS)). Exclusions: YMRS score <20; no previous history of mania; schizoaffective disorder; rapid cycling bipolar disorder; borderline or antisocial personality disorder; neuroleptic malignant syndrome; substance abuse or dependence; other medical conditions; pregnant or nursing; not taking contraception; or at risk of violent or suicidal behaviour.

Embedded ImageIntervention:

The efficacy of risperidone in bipolar disorder was …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.